"Whether regenerative medicine is headed towards translation or even more fundamental discovery, I think now is a time of just an explosion of possibilities."
Can nanotechology prevent a silent killer?
Medicine by Design-funded foundational technology grows into biotech success story: Notch Therapeutics closes an $85 million Series A financing
Medicine by Design-funded research program that aims to generate next-generation immunomodulation therapies has seeded a Canadian biotechnology success story with the closing of an $85-million (U.S.) Series A financing.
Medicine by Design's $4-million Pivotal Experiment Fund aims to bridge one of the critical gaps in the “valley of death” between a research discovery and a translatable therapy.
"I wanted to be a researcher since I was 14. As I studied more, I became inspired by the idea of developing treatments for challenging diseases that have limited treatment options. That's why I chose a PhD in spinal cord injury and a post-doc in abdominal aortic aneurysm."
Research team’s ongoing work on using stem cells to encourage brain and muscle to self-repair has celebrated successes
Building a Biotech Venture to help Medicine by Design trainees take first steps toward entrepreneurship
New partnership with Health Innovation Hub offers a focused workshop, expert mentoring, and pitch competition with up to $25,000 in funding on offer to further develop product or venture
"We have an aging population. Our biggest problems are degenerative diseases that we need to learn how to stall or turn around. It's an amazing set of problems to work on because of the potential for impact."
An interdisciplinary team of scientists, funded by Medicine by Design, aims to use retinal stem cells to restore vision.
"I’m really interested in understanding why and how the heart fails, and how we can help the heart to regenerate itself. As a cardiologist who looks after patients with end-stage heart failure waiting for heart transplants and mechanical hearts, it’s really important to me to think outside the box about these questions."
Medicine by Design symposium highlights importance of convergence in advancing regenerative medicine and human health
Medicine by Design’s 5th Annual Symposium on Dec. 7 and 8 attracted more than 500 registrants from across North America, and focused on the theme of better science through convergence – the integration of approaches from engineering, science, medicine and other fields to expand knowledge and spark innovation.
Team led by pioneering stem cell scientist is one step closer to the clinic with cell-based therapies for liver disease.
Competition aims to redefine regenerative medicine and ensure Toronto and Canada continue to lead the field for decades to come
“I've always been fascinated by the brain. I’m fascinated with questions of basic science, but I’d like my bigger impact to be teaching and educating young scientists.”
Using state-of-the art sequencing technology, Medicine by Design-funded scientists have revealed how stem cells are able to generate new blood cells throughout our life, and how these same cellular mechanisms can evade chemotherapy to survive and cause relapse many years later.